In contrast, cytokeratin 18 (KRT18) was strongly overexpressed in both NEC-like IDH2 and NEC-like SMARCA4/ARID1A cancers but not in olfactory neuroblastoma. This evidence concerns the gene SMARCA4 and neuroendocrine carcinoma.